Instrument Inactif

Communiqués Plasmatech Biopharmaceuticals Inc Nasdaq

Actions

US72754H1095

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

18/06	Abeona Therapeutics dépose une déclaration d'enregistrement pour une offre mixte de 300 millions de dollars, 75 millions de dollars sur le marché	MT
05/06	Les marchés restent à l'horizontale

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	07/06	PR
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/06	AQ
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers	03/06	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	31/05	PR
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference	28/05	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	23/05	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	17/05	PR
Abeona Therapeutics: Q1 Earnings Snapshot	15/05	AQ
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress	15/05	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	07/05	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	07/05	PR
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	06/05	AQ
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	03/05	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	02/05	BU
Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	02/05	BU
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	30/04	BU
Abeona Therapeutics Provides Regulatory Update on Pz-cel	22/04	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01/04	AQ
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections	18/03	AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	06/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Plasmatech Biopharmaceuticals Inc Nasdaq

Actions

US72754H1095

Communiqués

Filtres